Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically ...
Asharq Al-Awsat on MSN
Lebanon enters conflict management phase as end remains elusive
Beirut: Negotiations to cement the ceasefire in southern Lebanon, alongside talks on the future of the south, the role of the Lebanese army and international guarantees, are raising a central question ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results